That doesn't necessarily mean they aren't looking at it. Many breakthrough therapy designations have already been granted for psilocybin in the treatment of resistant depression—that is, depression that does not respond to at the least two differing kinds of antidepressants—along with a broader approval may very well be over the horizon.Third W… Read More